U

United Laboratories International Holdings Ltd
HKEX:3933

Watchlist Manager
United Laboratories International Holdings Ltd
HKEX:3933
Watchlist
Price: 10.12 HKD Market Closed
Market Cap: 18.4B HKD
Have any thoughts about
United Laboratories International Holdings Ltd?
Write Note

United Laboratories International Holdings Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

United Laboratories International Holdings Ltd
Total Equity Peer Comparison

Comparables:
G
512
1177
C
570
C
3320
H
13

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
U
United Laboratories International Holdings Ltd
HKEX:3933
Total Equity
ÂĄ13.5B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
9%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Total Equity
HK$15.7B
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
33%
Sino Biopharmaceutical Ltd
HKEX:1177
Total Equity
ÂĄ32.8B
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
22%
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Total Equity
ÂĄ21.4B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
22%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Total Equity
HK$48.4B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Total Equity
$740.1m
CAGR 3-Years
-9%
CAGR 5-Years
16%
CAGR 10-Years
23%

See Also

What is United Laboratories International Holdings Ltd's Total Equity?
Total Equity
13.5B CNY

Based on the financial report for Jun 30, 2024, United Laboratories International Holdings Ltd's Total Equity amounts to 13.5B CNY.

What is United Laboratories International Holdings Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
9%

Over the last year, the Total Equity growth was 17%. The average annual Total Equity growth rates for United Laboratories International Holdings Ltd have been 14% over the past three years , 16% over the past five years , and 9% over the past ten years .

Back to Top